Home
About
Services
Partners
Client Portfolio
News
Contact
Asia stocks track Wall Street rise, U.S.-EU meet keeps trade in focus
July 25, 2018
Deutsche Bank second-quarter net profit drops as new CEO overhauls lender
July 25, 2018
0
Biogen easily tops Street estimates on Spinraza sales, raises forecast
Published by
Muller&Green
at
July 25, 2018
Categories
RSS
Tags
Biogen Inc reported far better-than-expected second quarter profit on Tuesday, driven by strong demand of its Spinraza muscle disease treatment, and the U.S. biotech company raised its full-year profit forecast.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more